Anal Fissure Treatment Market Industry Analysis: Assessing Business Growth and Market Expansion Strategies for Success | Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma

Global Anal Fissure Treatment Market is estimated to be valued at US$ 1,039.3 Mn in 2023, and is expected to reach US$ 1,491.9 Mn by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030.

Market Overview:

Anal fissures are small tears or cracks in the anal canal lining. Common symptoms include pain and bleeding during and after bowel movements. Anal fissures occur most often due to constipation or hard stools that cause prolonged pressure and trauma to the anal canal.

Market Dynamics:

Rising prevalence of anorectal diseases such as hemorrhoids and constipation are key factors promoting the growth of anal fissure treatment market. For instance, according to the National Institutes of Health, approximately 1/3rd of U.S. adults experience hemorrhoids annually. Moreover, changing lifestyle resulting into unhealthy eating habits and lack of physical activity are increasing the risk of constipation among population globally. Constipation is one of the common causes of anal fissures. Furthermore, advancements in anal fissure treatment drugs and surgical procedures are also fueling the market growth. Major players are focused on developing non-surgical therapies to overcome the limitations of surgical treatment options.

Get an Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/6358

Rising Prevalence of Anal Fissures is Major Market Driver

The rising prevalence of anal fissures globally is one of the major drivers boosting the growth of anal fissure treatment market. Anal fissures are fairly common and nearly everyone experiences a tear or cut in the anal area at some point. Often they heal on their own, however, in some cases pain persists and they do not heal, which requires medical treatment. According to estimates, about 11% of individuals will develop an anal fissure in their lifetime. Factors such as constipation, passing hard stools, and anal trauma make people more prone to developing anal fissures. With changing lifestyles and diet patterns, constipation has become more prevalent, thus increasing the risk of anal fissures. Additionally, genetics also plays a role in persistence of anal fissures in some individuals. The high and rising prevalence of anal fissures globally has increased the demand for effective treatment options such as topical nitroglycerin, calcium channel blockers, botulinum toxins, and surgery. This serves as a major market driver.

Increasing Obesity Rates Fuelling Demand for Anal Fissure Treatment

Rising obesity rates worldwide is another key factor augmenting the growth of the anal fissure treatment market. Obesity is a major risk factor that can increase the chances of developing anal fissures. Obese individuals are more likely to suffer from constipation issues which in turn elevates the risk of anal fissure. According to the World Health Organization (WHO), global obesity rates have nearly tripled since 1975. In 2016, over 1.9 billion adults aged 18 years and older were overweight out of which 650 million were obese. The rising obese population suffers from anal fissures with higher frequency. Since obesity levels continue to climb each year globally due to sedentary lifestyles and unhealthy eating, more number of people will require treatment for anal fissures, thus propping up demand for anal fissure treatment drugs and devices.

Availability of Alternatives Poses Threat

Availability of alternative treatment options poses a major challenge for the growth of the anal fissure treatment market. Several alternative therapies such as sitz baths, topical aloe vera and chamomile, vitamin supplements, tea tree oil, etc. are commonly used to relieve symptoms of anal fissures naturally. Many people suffering from mild anal fissures initially try home remedies and alternative therapies before seeking medical treatment. This reduces their dependence on prescription medications and surgical procedures in the initial stages. A large section prefers alternative treatments due to cost-effectiveness, avoidance of side effects, and ease of use. This deters them from opting for conventional anal fissure treatment options such as drugs, which poses a restraint on the market. Players need to create more awareness about efficacy of prescription treatments to counter the threat from alternative treatments.

Technological Advancements Provide Opportunity for Market Growth

Continuous technological developments in the field of anal fissure treatment provide significant growth opportunities for players in the market. Researchers are focusing on developing newer drugs and medical devices with better healing abilities and fewer side effects. For instance, companies are engaged in R&D activities for developing topical nanoemulsion and lipid-based drug delivery systems for more effective localized treatment of anal fissures. Advancements have also been made in the area of minimally invasive surgical techniques. Developments such as advancement in laser therapy methods, procedure technologies, tissue welding, etc. help perform surgeries for chronic anal fissures more efficiently. Market players could gain advantages by investing in R&D and bringing novel technologically advanced treatment options to cater to unmet needs of patients and physicians. This presents lucrative opportunities for businesses to diversify their product portfolios and strengthen their market position.

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/6358

Rise in Self-Care Trend Stimulating OTC Anal Fissure Treatment Sales

The increasing trend of self-care and self-medication is one of the major ongoing trends spurring the sales of over-the-counter (OTC) anal fissure treatment products such as creams and ointments. People prefer using inexpensive OTC drugs for minor problems to avoid expenses and time spent on doctors' consultations.

Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, a detailed analysis of the competitive landscape, and product services of key players. Analysis of Anal Fissure Treatment companies, key tactics followed by Leading Key Players:

Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences , Healthy Life Pharma Private Limited, Geri-Care Pharmaceuticals Corp

Note: Major Players are sorted in no particular order.

By Treatment Type

Laxatives
Topical Nitrates
Calcium Channel Blockers
Stool Softeners
Surgery
Others

By Route of Administration

Oral
Topical
Others

By Drugs

Nitroglycerin
Diltiazem
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

The Study Objectives are:

A comprehensive insight into key players operating in the Anal Fissure Treatment Market and their corresponding data.
It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
Regional analysis, which includes insight into the dominant market and corresponding market share.
It also includes various socio-economic factors affecting the evolution of the market in the region.
The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Contents:

Market scenario 2023

Chapter 1: Introduction, Market Driving Force Product Objective of Study and Research Scope the Anal Fissure Treatment market
Chapter 2: Exclusive Summary - the basic information of the Anal Fissure Treatment Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends, and Challenges & Opportunities of the Anal Fissure Treatment
Chapter 4: Presenting the Anal Fissure Treatment Market Factor Analysis, Supply/Value Chain, PESTEL analysis, Market Entry, and Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User, and Region/Country 2023 - 2030
Chapter 6: Evaluating the leading manufacturers of the Anal Fissure Treatment market which consists of its Competitive Landscape, Peer Group Analysis, Market positioning & Company Profile
Chapter 7: To evaluate the market by segments, by countries, and by Manufacturers/Companies with revenue share and sales by key countries in these various regions (2023-2030)
Chapters 8 & 9: Displaying the Appendix, Methodology, and Data Source

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/6358

Key Questions Answered:

What is the market size and CAGR of the Anal Fissure Treatment Market during the forecast period?
How is the growing demand impacting the growth of Anal Fissure Treatment Market shares?
What is the growing demand of the Market during the forecast period?
Who are the leading vendors in the market and what are their market shares?
What is the impact of the COVID-19 pandemic on the APAC Anal Fissure Treatment Market?

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.